WithdrawnNCT05956600
This study exists to understand whether a therapy or guided support program is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Global
- Sponsor
- University of California, Los Angeles
- Condition
- Schizophrenia
CompletedNCT05341804
This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 40 Years to 75 Years
- Countries
- Taiwan
- Sponsor
- Kaohsiung Medical University Chung-Ho Memorial Hospital
- Condition
- Schizophrenia
CompletedNCT03768674
This study exists to learn from real-world information that can show how a digital app or remote support tool fits into care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- Norway
- Sponsor
- Oslo University Hospital
- Condition
- Schizophrenia
CompletedNCT04143308
This study exists to see whether a therapy or guided support program can play a useful role in care. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 20 Years to 60 Years
- Countries
- Taiwan
- Sponsor
- Kaohsiung Medical University Chung-Ho Memorial Hospital
- Condition
- Schizophrenia
CompletedNCT01098110
This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
SchizophreniaOtherFrom 20 Years to 64 Years
- Countries
- Global
- Sponsor
- Organon and Co
- Condition
- Schizophrenia
CompletedNCT04916496
This study exists to understand how acceptance and commitment therapy, a talking treatment, holds up over time after the earliest research stage. Researchers are trying to understand whether acceptance and commitment therapy, a talking treatment, can give earlier or clearer feedback during care.
SchizophreniaOtherOver 18 Years
- Countries
- China
- Sponsor
- Chinese University of Hong Kong
- Condition
- Schizophrenia
RecruitingNCT06231732
This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherOver 18 Years
- Countries
- China
- Sponsor
- Sir Run Run Shaw Hospital
- Condition
- Schizophrenia
CompletedNCT01617187
This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand whether a medication treatment can give earlier or clearer feedback during care.
SchizophreniaOtherOver 18 Years
- Countries
- Global
- Sponsor
- Organon and Co
- Condition
- Schizophrenia
RecruitingNCT06186570
This study exists to see whether a guided support group can make care clearer and more responsive. Researchers are trying to understand whether a guided support group can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 75 Years
- Countries
- Germany
- Sponsor
- Charite University, Berlin, Germany
- Condition
- Schizophrenia
CompletedNCT04524403
This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Corcept Therapeutics
- Condition
- Schizophrenia
TerminatedNCT03077347
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 35 Years
- Countries
- United States
- Sponsor
- University of California, Davis
- Condition
- Schizophrenia
TerminatedNCT05643170
This study exists to understand how questionnaires and follow-up reports holds up over time after the earliest research stage. Researchers are trying to understand whether questionnaires and follow-up reports can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Condition
- Schizophrenia
CompletedNCT05210816
This study exists to see whether acceptance and commitment therapy, a talking treatment, can play a useful role in care. Researchers are trying to understand whether acceptance and commitment therapy, a talking treatment, can make support easier to access outside standard clinic visits.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Turkey
- Sponsor
- Saglik Bilimleri Universitesi
- Condition
- Schizophrenia
CompletedNCT03260257
This study exists to understand how brain scans or other body measurements holds up over time after the earliest research stage. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- University of California, San Diego
- Condition
- Schizophrenia
RecruitingNCT05206292
This study exists to see whether brain scans or other body measurements can make care clearer and more responsive. Researchers are trying to understand whether brain scans or other body measurements can give earlier or clearer feedback during care.
SchizophreniaOtherOver 18 Years
- Countries
- France
- Sponsor
- University Hospital, Grenoble
- Condition
- Schizophrenia
RecruitingNCT06431009
This study exists to understand how smoking support or smoking-related treatment holds up over time after the earliest research stage. Researchers are trying to understand whether smoking support or smoking-related treatment can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherOver 15 Years
- Countries
- Denmark
- Sponsor
- University of Aarhus
- Condition
- Schizophrenia
CompletedNCT01142596
This study exists to understand how the medication Asenapine holds up over time after the earliest research stage. Researchers are trying to understand how people respond to the medication Asenapine in practice and what may need to be adjusted.
SchizophreniaOtherFrom 20 Years to 64 Years
- Countries
- Global
- Sponsor
- Organon and Co
- Condition
- Schizophrenia
CompletedNCT01244828
This study exists to understand how the medication Asenapine holds up over time after the earliest research stage. Researchers are trying to understand what the medication Asenapine could change in day-to-day care and decision-making.
SchizophreniaOtherOver 20 Years
- Countries
- Global
- Sponsor
- Organon and Co
- Condition
- Schizophrenia
TerminatedNCT03896945
This study exists to compare options and see whether the medication AVP-786 offers something meaningfully different. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- Bulgaria, Poland, United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Schizophrenia
TerminatedNCT02261519
This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand whether a therapy or guided support program can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 45 Years
- Countries
- United States
- Sponsor
- SyneuRx International (Taiwan) Corp
- Condition
- Schizophrenia
RecruitingNCT06423651
This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 16 Years to 55 Years
- Countries
- Spain
- Sponsor
- Universitat Autonoma de Barcelona
- Condition
- Schizophrenia
CompletedNCT01190267
This study exists to understand how the medication Asenapine holds up over time after the earliest research stage. Researchers are trying to understand how people respond to the medication Asenapine in practice and what may need to be adjusted.
SchizophreniaOtherFrom 12 Years to 17 Years
- Countries
- Global
- Sponsor
- Organon and Co
- Condition
- Schizophrenia
CompletedNCT01190254
This study exists to see whether the medication Asenapine can play a useful role in care. Researchers are trying to understand how people respond to the medication Asenapine in practice and what may need to be adjusted.
SchizophreniaOtherFrom 12 Years to 17 Years
- Countries
- Global
- Sponsor
- Organon and Co
- Condition
- Schizophrenia
RecruitingNCT05567575
This study exists to understand how cognitive behavioural therapy, a structured talking treatment, holds up over time after the earliest research stage. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can make support easier to access outside standard clinic visits.
SchizophreniaOtherOver 18 Years
- Countries
- Pakistan
- Sponsor
- Pakistan Institute of Living and Learning
- Condition
- Schizophrenia
Not Yet RecruitingNCT03974620
This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 35 Years
- Countries
- Global
- Sponsor
- Pakistan Institute of Living and Learning
- Condition
- Schizophrenia
